Intra-Cellular Therapies Inc

Common Name
Intra-Cellular Therapies
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
860
Ticker
ITCI
Exchange
NASDAQ/NGS
Description
Intra-Cellular Therapies Inc. is a biopharmaceutical company that innovates in the development of novel drugs for treating complex psychiatric and neurological disorders. Its primary focus is on treat...

Intra-Cellular Therapies's GHG Emissions Data Preview

In 2023, Intra-Cellular Therapies completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources).

However, Intra-Cellular Therapies has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Market-Based
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Location-Based
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Download Data

Verified Sources Behind Intra-Cellular Therapies’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Intra-Cellular Therapies’s data sources below and access millions more through our Disclosure Search.

a. Intra-Cellular Therapies's Sustainability Report 2023
a. Intra-Cellular Therapies's Sustainability Report 2023

Insights into Intra-Cellular Therapies's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Intra-Cellular Therapies amounted to 3,907 metric tons of CO2 equivalent. This figure reflects direct emissions from owned or controlled sources (Scope 1). a

Intra-Cellular Therapies's Scope 1 Emissions Over Time

202301 k2 k3 k4 ktCO2e
  • Total Scope 1
  • Year-over-Year Change

What are Intra-Cellular Therapies's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Intra-Cellular Therapies were 3,907 metric tons of CO₂ equivalent (tCO₂e). a

Want Full Access to Intra-Cellular Therapies's GHG Emissions Dataset?
Sign Up